Novian Health commences multicenter Novilase Interstitial Laser Therapy clinical tria
Novian Health, developer of Novilase Breast Therapy, announced the company has begun a multicenter clinical trial on the use of Novilase Interstitial Laser Therapy (ILT) for the destruction of malignant breast tumors.